An introduction to murine models of atrial fibrillation

Frontiers in Physiology

Volumn 3 AUG, Issue , 2012, Pages

  Riley, Genna ^a   Syeda, Fahima ^a   Kirchhof, Paulus ^a,b   Fabritz, Larissa ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Atrial fibrillation; Atrial tachycardia; Cardiac function; Electrocardiogram; Electrophysiology; Mouse heart; Murine model; Sick sinus syndrome

Indexed keywords

EID: 84866491005     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00296     Document Type: Review

References (183)

1. Adam, O., Frost, G., Custodis, F., Suss-man, M. A., Schäfers, H. J., Böhm, M., and Laufs, U. (2007). Role of Rac1 GTPase activation in atrial fibrillation. J. Am. Coll. Cardiol. 50, 359-367.
2. Adam,O.,Lavall,D.,Theobald,K.,Hohl, M., Grube, M., Ameling, S., Suss-man, M. A., Rosenkranz, S., Kroe-mer, H. K., Schäfers, H. J., Böhm, M., and Laufs, U. (2010). Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J. Am. Coll. Cardiol. 55, 469-480.
3. Allessie, M., Schotten, U., Verheule, S., and Harks, E. (2005). Gene therapy for repair of cardiac fibrosis: a long way to Tipperary. Circulation 111, 391-393.
4. Arad, M., Moskowitz, I. P., Patel, V. V., Ahmad, F., Perez-Atayde, A. R., Sawyer, D. B., Walter, M., Li, G. H., Burgon, P. G., Maguire, C. T., Stapleton, D., Schmitt, J. P., Guo, X. X., Pizard, A., Kuper-shmidt, S., Roden, D. M., Berul, C. I., Seidman, C. E., and Seid-man, J. G. (2003). Transgenic mice overexpressing mutant PRKAG2 define the causeofWolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107, 2850-2856.
5. Aronheim, A., Zandi, E., Hennemann, H., Elledge, S. J., and Karin, M. (1997). Isolation of an AP-1 repres-sor by a novel method for detectingprotein-protein interactions. Mol. Cell. Biol. 17, 3094-3102.
6. Asahi, M., Nakayama, H., Tada, M., and Otsu, K. (2003). Regulation of sarco(endo)plasmic reticu-lum Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for cardiac hypertrophy and failure. Trends Cardiovasc. Med. 13, 152-157.
7. Babu, G. J., Bhupathy, P., Carnes, C. A., Billman, G. E., and Periasamy, M. (2007a). Differential expression of sarcolipin protein during muscle development and cardiac patho-physiology. J. Mol. Cell. Cardiol. 43, 215-222.
8. Babu, G. J., Bhupathy, P., Timofeyev, V., Petrashevskaya, N. N., Reiser, P. J., Chiamvimonvat, N., and Peri-asamy, M. (2007b). Ablation of sar-colipin enhances sarcoplasmic retic-ulum calcium transport and atrial contractility. Proc. Natl. Acad. Sci. U.S.A. 104, 17867-17872.
9. Bardeesy, N., Sinha, M., Hezel,A. F., Sig-noretti, S., Hathaway, N. A., Sharp-less, N. E., Loda, M., Carrasco, D. R., and DePinho, R. A. (2002). Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162-167.
10. Ben-Ami, I., Yao, Z., Naor, Z., and Seger,R. (2011). Gq protein-induced apoptosis is mediated byAKT kinase inhibition that leads to protein kinase C-induced c-Jun N-terminal kinase activation. J. Biol. Chem. 286, 31022-31031.
11. Bennett, V., and Gilligan, D. M. (1993). The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu. Rev. Cell Biol. 9, 27-66.
12. Bhupathy, P., Babu, G. J., Ito, M., and Periasamy, M. (2009). Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes. J. Mol. Cell. Cardiol. 47, 723-729.
13. Black, R. G. Jr., Guo, Y., Ge, Z. D., Mur-phree, S. S., Prabhu, S. D., Jones, W. K., Bolli, R., and Auchampach, J. A. (2002). Gene dosage-dependent effects of cardiac-specific overex-pression of the A3 adenosine receptor. Circ. Res. 91, 165-172.
14. Blana,A., Kaese, S., Fortmüller, L., Laak-mann, S., Damke, D., van Bragt, K., Eckstein, J., Piccini, I., Kirchhefer, U., Nattel, S., Breithardt, G., Carmeliet, P., Carmeliet, E., Schotten, U., Ver-heule, S., Kirchhof, P., and Fabritz, L. (2010). Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability. Heart Rhythm 7, 1862-1869.
15. Boldt, A., Wetzel, U., Weigl, J., Gar-bade, J., Lauschke, J., Hindricks, G., Kottkamp, H., Gummert, J. F., and Dhein, S. (2003). Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J. Am. Coll. Cardiol. 42, 1785-1792.
16. Bond, C. T., Herson, P. S., Strassmaier, T., Hammond, R., Stackman, R., Maylie, J., and Adelman, J. P. (2004). Small conductance Ca2+-activated K+ channel knock-out mice reveal the identity of calcium-dependent afterhyperpolarization currents. J. Neurosci. 24, 5301-5306.
17. Borrmann, C. M., Grund, C., Kuhn, C., Hofmann, I., Pieperhoff, S., and Franke,W.W. (2006). The area com-posita of adhering junctions connecting heart muscle cells of vertebrates. II. Colocalizations of desmo-somal and fascia adhaerens molecules in the intercalated disk. Eur. J. Cell Biol. 85, 469-485.
18. Bouvagnet, P., Neveu, S., Montoya, M., and Leger, J. J. (1987). Development changes in the human cardiac isomyosin distribution:animmuno-histochemical study using monoclonal antibodies. Circ. Res. 61, 329-336.
19. Burstein, B., Libby, E., Calderone, A., and Nattel, S. (2008). Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117, 1630-1641.
20. Callis,T.E.,Pandya,K.,Seok,H.Y., Tang, R. H., Tatsuguchi, M., Huang, Z. P., Chen, J. F., Deng, Z., Gunn, B., Shumate, J., Willis,M. S., Selzman,C. H., and Wang,D. Z. (2009). MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772-2786.
21. Camm, A. J., Kirchhof, P., Lip, G. Y., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., Al-Attar, N., Hin-dricks, G., Prendergast, B., Heid-buchel, H., Alfieri, O., Angelini, A., Atar, D., Colonna, P., De Caterina, R., De Sutter, J., Goette, A., Gorenek, B., Heldal, M., Hohloser, S. H., Kolh, P., Le Heuzey, J. Y., Ponikowski, P., and Rutten, F. H. (2010). Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart J. 31, 2369-2429.
22. Cao, Y., Zhang, J., Meng, X., and Wang, D. (2011). TNF-alpha induces early growth response gene-1 expression via ERK1/2 activation in endothelial cells. Acta Diabetol.
23. Chauhan, V. S., Tuvia, S., Buhusi, M., Bennett, V., and Grant, A. O. (2000). Abnormal cardiac Na(+) channel properties andQTheartrate adaptation in neonatal ankyrin(B) knockout mice. Circ. Res. 86, 441-447.
24. Chelu, M. G., Sarma, S., Sood, S., Wang, S., van Oort, R. J., Skapura, D. G., Li, N., Santonastasi, M., Müller,F. U., Schmitz,W., Schotten,U.,Anderson, M. E., Valderrábano, M., Dobrev, D., andWehrens,X.H. (2009). Calmod-ulin kinase II-mediated sarcoplas-mic reticulum Ca2+ leak promotes atrial fibrillation in mice. J. Clin. Invest. 119, 1940-1951.
25. Chen, H. H., Baty, C. J., Maeda, T., Brooks, S., Baker, L. C., Ueyama, T., Gursoy, E., Saba, S., Salama, G., London, B., and Stewart, A. F. (2004). Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered con-nexin phosphorylation. Circulation 110, 2980-2987.
26. Chiello Tracy, C., Cabo,C., Coromilas, J., Kurokawa, J., Kass, R. S., and Wit, A. L. (2003). Electrophysiological consequences of human IKs channel expression in adult murine heart. Am. J. Physiol. Heart Circ. Physiol. 284, H168-H175.
27. Chinchilla, A., Daimi, H., Lozano-Velasco, E., Dominguez, J. N., Caballero, R., Delpón, E., Tamargo, J., Cinca, J., Hove-Madsen, L., Aranega, A. E., and Franco, D. (2011). PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmo-genesis. Circ. Cardiovasc. Genet. 4, 269-279.
28. Chizzonite, R. A., Everett, A. W., Clark, W. A., Jakovcic, S., Rabinowitz, M., and Zak, R. (1982). Isolation and characterization of two molecular variants of myosin heavy chain fromrabbit ventricle. Changein their content during normal growth and after treatment with thyroid hormone. J. Biol. Chem. 257, 2056-2065.
29. Choi, E. K., Chang, P. C., Lee, Y. S., Lin, S. F., Zhu, W., Maruyama, M., Fish-bein, M. C., Chen, Z., Rubart-von der Lohe, M., Field,L. J., and Chen, P. S. (2012). Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-beta1. Circ. J. 76, 1354-1362.
30. Colbert, M. C., Hall, D. G., Kimball, T. R., Witt, S. A., Lorenz, J. N., Kirby, M. L., Hewett, T. E., Klevit-sky, R., and Robbins, J. (1997). Cardiac compartment-specific overex-pression of a modified retinoic acid receptor produces dilated cardiomy-opathy and congestive heart failure in transgenic mice. J. Clin. Invest. 100, 1958-1968.
31. Cong, H., Li, X., Ma, L., Jiang, H., Mao, Y., and Xu, M. (2010). Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation. J. Thorac. Cardio-vasc. Surg. 140, 298-304.
32. Creemers, E. E., and Pinto,Y. M. (2011). Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 89, 265-272.
33. Cunha, S. R., Hund, T. J., Hashemi, S., Voigt, N., Li, N., Wright, P., Koval, O., Li, J., Gudmundsson, H., Gumina, R. J., Karck, M., Schott, J. J., Probst, V., Le Marec, H., Anderson, M. E., Dobrev, D., Wehrens, X. H., and Mohler, P. J. (2011). Defectsinankyrin-based membrane protein targeting pathways underlie atrial fibrillation. Circulation 124, 1212-1222.
34. D'Angelo, D. D., Sakata, Y., Lorenz, J. N., Boivin, G. P., Walsh, R. A., Liggett, S. B., and Dorn, G. W. II. (1997). Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. U.S.A. 94, 8121-8126.
35. Dautova,Y., Zhang,Y., Sabir, I.,Grace, A. A., and Huang, C. L. (2009). Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome. Pflugers Arch. 458, 443-457.
36. de Diego,C., Chen, F.,Xie,L. H., Dave,A. S., Thu, M., Rongey, C., Weiss, J. N., and Valderrábano, M. (2008). Cardiac alternans in embryonic mouse ventricles. Am. J. Physiol. Heart Circ. Physiol. 294, H433-H440.
37. De Jong,A. M., Maass,A. H.,Oberdorf-Maass, S. U., Van Veldhuisen, D. J., Van Gilst, W. H., and Van Gelder,I. C. (2011). Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc. Res. 89, 754-765.
38. De Mello, W. C, and Frohlich, E. D. (2011). On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides 32, 1774-1779.
39. Deng, Y. H., Alex, D., Huang, H. Q., Wang, N., Yu, N., Wang, Y T., Leung, G. P., and Lee, S. M. (2011). Inhibition of TNF-alpha-mediated endothelial cell-mo no cyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,47-trimethoxystilbene. Phytother. Res. 25, 451-457.
40. DiMarco, J. P., Sellers, T. D., Berne, R. M., West, G. A., and Belardinelli, L. (1983). Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68, 1254-1263.
41. Eckardt, L., Kirchhof, P., Loh, P., Schulze-Bahr, E., Johna, R., Wichter, T., Breithardt, G., Haverkamp, W., and Borggrefe, M. (2001). Bru-gada syndrome and supraventricular tachyarrhythmias: a novel association? J. Cardiovasc. Electrophysiol. 12, 680-685.
42. Eloff, B. C., Lerner, D. L., Yamada, K. A., Schuessler, R. B., Saffitz, J. E., and Rosenbaum, D. S. (2001). High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc. Res. 51, 681-690.
43. Fabritz, L., Kirchhof, P., Fortmüller, L., Auchampach, J. A., Baba, H. A., Breithardt, G., Neumann, J., Boknik, P., and Schmitz, W. (2004). Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc. Res. 62, 500-508.
44. Fabritz, L., Kirchhof, P., Franz, M. R., Eckardt, L., Mönnig, G., Milberg, P., Breithardt, G., and Haverkamp, W (2003). Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res. Cardiol. 98,25-32.
45. Filtz, T. M., Grubb, D. R., McLeod-Dryden, T. J., Luo, J., and Woodcock, E.A. (2009). Gq-initiatedcardiomy-ocyte hypertrophy is mediated by phospholipase Cbeta1b. FASEBJ. 23, 3564-3570.
46. Foulkes, N. S., Borrelli, E., and Sassone-Corsi, P. (1991). CREM gene: use ofalternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 64, 739-749.
47. Franke, W. W., Borrmann, C. M., Grund, C., and Pieperhoff,S. (2006). The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins. Eur. J. Cell Biol. 85, 69-82.
48. Gage, P. J., Suh, H., and Camper, S. A. (1999). Dosage requirement of Pitx2 for development of multiple organs. Development 126, 4643-4651.
49. Ganga, M., Espinoza, H. M., Cox, C. J., Morton, L., Hjalt, T. A., Lee, Y., and Amendt, B. A. (2003). PITX2 isoform-specific regulation of atrial natriuretic factor expression: syner-gism and repression with Nkx2.5. J. Biol. Chem. 278, 22437-22445.
50. Gellens, M. E., George, A. L. Jr., Chen, L. Q., Chahine, M., Horn, R., Barchi, R. L., and Kallen, R. G. (1992). Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc. Natl. Acad. Sci. U.S.A. 89, 554-558.
51. Goddard, C. A., Ghais, N. S., Zhang, Y., Williams, A. J., Colledge, W. H., Grace, A. A., and Huang, C. L. (2008). Physiological consequences of the P2328S mutation in the ryan-odine receptor(RyR2) geneingenet-ically modified murine hearts. Acta Physiol. (Oxf.) 194, 123-140.
52. Gollob, M. H., Jones, D. L., Krahn,A. D., Danis, L., Gong, X. Q., Shao, Q., Liu, X., Veinot, J. P., Tang, A. S., Stewart, A. F., Tesson, F., Klein, G. J., Yee, R., Skanes,A.C.,Guiraudon,G.M.,Ebi-hara, L., and Bai, D. (2006). Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N. Engl. J. Med. 354, 2677-2688.
53. Groenewegen, W. A., Firouzi, M., Bezzina, C. R., Vliex, S., van Langen, I. M., Sandkuijl, L., Smits, J. P., Huls-beek, M., Rook, M. B., Jongsma, H. J., and Wilde, A. A. (2003). A cardiac sodium channel mutation cosegre-gates with a rare connexin40 genotype in familial atrial standstill. Circ. Res. 92, 14-22.
54. Gudbjartsson, D. F., Arnar, D. O., Hel-gadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., Jonasdottir, A., Baker, A., Thorleifsson, G., Krist-jansson, K., Palsson, A., Blondal, T., Sulem, P., Backman, V. M., Hardar-son, G. A., Palsdottir, E., Helgason, A., Sigurjonsdottir, R., Sverrisson, J. T., Kostulas, K., Ng, M. C., Baum, L., So, W. Y., Wong, K. S., Chan, J.C., Furie, K. L., Greenberg, S. M., Sale, M., Kelly, P., MacRae, C. A., Smith, E. E., Rosand, J., Hillert, J., Ma, R. C., Ellinor, P. T., Thorgeirs-son, G., Gulcher, J. R., Kong, A., Thorsteinsdottir, U., and Stefansson, K. (2007). Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448, 353-357.
55. Guzadhur, L., Pearcey, S. M., Duehmke, R. M., Jeevaratnam, K., Hohmann, A. F., Zhang, Y., Grace, A. A., Lei, M., and Huang, C. L. (2010). Atrial arrhythmogenicity in aged Scn5a+/deltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction. Pflugers Arch. 460, 593-601.
56. Hagendorff, A., Schumacher, B., Kirch-hoff, S., Lüderitz, B., and Willecke, K. (1999). Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99, 1508-1515.
57. Hakim, P., Brice, N., Thresher, R., Lawrence, J., Zhang, Y., Jackson, A. P., Grace, A. A., and Huang, C. L. (2010).Scn3b knockout mice exhibit abnormal sino-atrial and cardiac conduction properties. Acta Physiol. (Oxf.) 198, 47-59.
58. Hakim, P., Gurung, I. S., Pedersen, T. H., Thresher, R., Brice, N., Lawrence, J., Grace, A. A., and Huang, C. L. (2008).Scn3b knockout mice exhibit abnormal ventricular electrophysi-ological properties. Prog. Biophys. Mol. Biol. 98, 251-266.
59. Hao, X.,Zhang,Y., Zhang,X.,Nirmalan, M., Davies, L., Konstantinou, D., Yin, F., Dobrzynski, H., Wang, X., Grace, A., Zhang, H., Boyett, M., Huang, C. L., and Lei, M. (2011). TGF-beta1-mediated fibrosis and ion channel remodeling are key mechanisms in producing the sinus node dysfunction associated with SCN5A deficiency and aging. Circ. Arrhythm. Electrophysiol. 4, 397-406.
60. Head, C. E., Balasubramaniam, R., Thomas, G., Goddard, C. A., Lei, M., Colledge, W. H., Grace, A. A., and Huang, C. L. (2005). Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice. J. Cardiovasc. Electrophysiol. 16, 1329-1340.
61. Headrick, J. P., Peart, J. N., Reichelt, M. E., and Haseler, L. J. (2011). Adeno-sine and its receptors in the heart: regulation, retaliation and adaptation. Biochim. Biophys. Acta 1808, 1413-1428.
62. Hein, L., Stevens, M. E., Barsh, G. S., Pratt, R. E., Kobilka, B. K., and Dzau, V. J. (1997). Overexpressionof angiotensin AT1 receptor trans-gene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl. Acad. Sci. U.S.A. 94, 6391-6396.
63. Herr, C., Smyth, N., Ullrich, S., Yun, F., Sasse, P., Hescheler, J., Fleis-chmann, B., Lasek, K., Brixius, K., Schwinger, R. H., Fässler, R., Schröder, R., and Noegel, A. A. (2001). Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine car-diomyocytes. Mol. Cell. Biol. 21, 4119-4128.
64. Hirose, M., Takeishi, Y., Niizeki, T., Shimojo, H., Nakada, T., Kub-ota, I., Nakayama, J., Mende, U., and Yamada, M. (2009). Diacylglyc-erol kinase zeta inhibits G(alpha)q-induced atrial remodeling in trans-genic mice. Heart Rhythm 6, 78-84.
65. Hong, C. S., Cho, M. C., Kwak, Y. G., Song, C. H., Lee, Y. H., Lim, J. S., Kwon,Y. K.,Chae,S. W., and Kim, D. H. (2002). Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin. FASEB J. 16, 1310-1312.
66. Hong, C. S., Kwon, S. J., Cho, M. C., Kwak, Y. G., Ha, K. C., Hong, B., Li, H., Chae,S.W., Chai,O. H., Song,C. H.,Li,Y., Kim,J. C.,Woo,S.H., Lee,S. Y., Lee,C. O., and Kim do,H. (2008). Overexpression of junctate induces cardiachypertrophy andarrhythmia via altered calcium handling. J. Mol. Cell. Cardiol. 44, 672-682.
67. Hoogaars, W. M., Engel, A., Brons, J. F., Verkerk, A. O., de Lange, F. J., Wong, L. Y., Bakker, M. L., Clout, D. E., Wakker, V., Barnett, P., Ravesloot, J. H., Moorman, A. F., Verheijck, E. E., and Christoffels, V. M. (2007). Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev. 21, 1098-1112.
68. Ikeda, Y., Sato, K., Pimentel, D. R., Sam, F., Shaw, R. J., Dyck, J. R., and Walsh, K. (2009). Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction. J. Biol. Chem. 284, 35839-35849.
69. Janse, M. J., and Rosen, M. R. (2006). History of arrhythmias. Handb. Exp. Pharmacol. 171, 1-39.
70. Jin, C., Ugai, H., Song, J., Murata, T., Nili, F., Sun, K., Horikoshi, M., and Yokoyama, K. K. (2001). Identification of mouse Jun dimerization protein 2 as a novel repressor of ATF-2. FEBS Lett. 489, 34-41.
71. Kääb, S., Darbar, D., van Noord, C., Dupuis, J., Pfeufer, A., Newton-Cheh, C., Schnabel, R., Makino, S., Sinner, M. F., Kannankeril, P. J.,Beckmann,B. M., Choudry,S., Donahue, B. S., Heeringa, J., Perz, S., Lunetta, K. L., Larson, M. G., Levy, D., MacRae, C. A., Ruskin, J. N., Wacker,A., Schömig,A., Wichmann, H. E., Steinbeck, G., Meitinger, T., Uitterlinden, A. G., Witteman, J. C., Roden, D. M., Benjamin, E. J., and Ellinor,P.T. (2009). Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur. Heart J. 30, 813-819.
72. Kahr, P. C., Piccini, I., Fabritz, L., Greber, B., Schöler, H., Scheld, H. H., Hoffmeier, A., Brown, N. A., and Kirchhof, P. (2011). Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue. PLoS ONE 6, e26389. doi:10.1371/journal.pone.0026389
73. Kasi, V. S., Xiao, H. D., Shang, L. L., Iravanian, S., Langberg, J., Witham, E. A., Jiao, Z., Gallego, C. J., Bernstein, K. E., and Dudley, S. C. Jr. (2007). Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation. Am. J. Physiol. Heart Circ. Physiol. 293, H182-H192.
74. Kehat, I., Accornero, F., Aronow, B. J., and Molkentin, J. D. (2011). Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins. J. Cell Biol. 193, 21-29.
75. Kehat, I., Heinrich, R., Ben-Izhak, O., Miyazaki, H., Gutkind, J. S., and Aronheim, A. (2006). Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation. Cardiovasc. Res. 70, 543-554.
76. Kirchhefer, U., Baba, H. A., Hanske, G., Jones, L. R., Kirchhof, P., Schmitz, W., and Neumann, J. (2004). Age-dependent biochemicaland contractile properties in atrium of trans-genic mice overexpressing junctin. Am. J. Physiol. Heart Circ. Physiol. 287, H2216-H2225.
77. Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosio, F., Crijns, H., Diener, H. C., Goette, A., Israel, C. W., Kuck, K. H., Lip, G. Y., Nattel, S., Page, R. L., Ravens, U., Schot-ten, U., Steinbeck, G., Vardas, P., Waldo, A., Wegscheider, K., Willems, S., and Breithardt, G. (2009). Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus con-ference" research perspectives in AF." Eur. Heart J. 30, 2969-2977c.
78. Kirchhof, P., Fabritz, L., Fortmuller, L., Matherne, G. P., Lankford, A., Baba, H. A., Schmitz, W., Breithardt, G., Neumann, J., and Boknik, P. (2003). Altered sinus nodal and atrioventric-ular nodal function in freely moving mice overexpressing the A1 adeno-sine receptor. Am. J. Physiol. Heart Circ. Physiol. 285, H145-H153.
79. Kirchhof, P., Klimas, J., Fabritz, L., Zwiener, M., Jones, L. R., Schäfers, M., Hermann, S., Boknik, P., Schmitz, W., Breithardt, G., Kirch-hefer, U., and Neumann, J. (2007). Stress and high heart rate provoke ventricular tachycardia in mice expressing triadin. J. Mol. Cell. Car-diol. 42, 962-971.
80. Kirchhof, P., Marijon, E., Fabritz, L., Li, N., Wang, W., Wang, T., Schulte, K., Hanstein, J., Schulte, J. S., Vogel, M., Mougenot, N., Laakmann, S., Fortmueller, L., Eckstein, J., Ver-heule, S., Kaese, S., Staab, A., Grote-Wessels, S., Schotten, U., Moubarak, G., Wehrens, X. H., Schmitz, W., Hatem, S., and Müller,F. U. (2011a). Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice. Int. J. Cardiol. PMID: 22093963. [Epub ahead of print].
81. Kirchhof, P., Kahr, P. C., Kaese, S., Piccini, I., Vokshi, I., Scheld, H. H., Rotering, H., Fortmueller, L., Laakmann, S., Verheule, S., Schot-ten, U., Fabritz, L., and Brown, N. A. (2011b). PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ. Cardiovasc. Genet. 4, 123-133.
82. Kirchhoff, S., Nelles, E., Hagendorff, A., Krüger, O., Traub, O., and Willecke, K. (1998). Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr. Biol. 8, 299-302.
83. Kitamura, K., Miura, H., Miyagawa-Tomita, S., Yanazawa, M., Katoh-Fukui, Y., Suzuki, R., Ohuchi, H., Suehiro, A., Motegi, Y., Nakahara, Y., Kondo, S., and Yokoyama, M. (1999). Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and peri-ocular mesoderm and right pulmonary isomerism. Development 126, 5749-5758.
84. Kosir, R., Juvan, P., Perse, M., Budefeld, T., Majdic, G., Fink, M., Sassone-Corsi, P., and Rozman, D. (2012). Novel insights into the downstream pathways and targets controlledby transcription factors CREM in the testis. PLoS ONE 7, e31798. doi:10.1371/journal.pone.0031798
85. C.S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J., and Feldman, A. M. (1997). Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ. Res. 81, 627-635.
86. Kupershmidt, S.,Yang, T., Anderson, M. E., Wessels, A., Niswender, K. D., Magnuson, M. A., and Roden, D. M. (1999). Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system. Circ. Res. 84, 146-152.
87. Laakmann, S., Fortmüller, L., Stümpel, F., Kirchhefer, U., Müller, F. U., Lutz, S., Wieland, T., Mende, U., Kirchhof, P., and Fabritz, L. (2010). Development of paroxysmal and periopera-tive atrial fibrillation and left atrial thrombi in Galphaq overexpressing mice. Clin. Res. Cardiol. 2010(99 Suppl. 1), 728.
88. Lamirault, G., Gaborit, N., Le Meur, N., Chevalier, C., Lande, G., Demolombe, S., Escande, D., Nattel, S., Léger, J. J., and Steenman, M. (2006). Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J. Mol. Cell. Cardiol. 40, 173-184.
89. Lang, D., Sulkin, M., Lou, Q., and Efi-mov, I. R. (2011). Optical mapping of action potentials and calcium transients in the mouse heart. J. Vis. Exp. 55, 3275.
90. Li, N., Timofeyev, V., Tuteja, D., Xu, D., Lu, L., Zhang, Q., Zhang, Z., Sin-gapuri, A., Albert, T. R., Rajagopal, A. V., Bond, C. T., Periasamy, M., Adelman, J., and Chiamvimonvat, N. (2009). Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J. Physiol. (Lond.) 587(Pt 5), 1087-1100.
91. Li, N., Wang, T., Wang, W., Cutler, M. J., Wang, Q., Voigt, N., Rosenbaum, D S., Dobrev, D., and Wehrens, X. H. (2012). Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ. Res. 110, 465-470.
92. Li, X., Moody, M. R., Engel, D., Walker, S., Clubb, F. J. Jr., Siva-subramanian, N., Mann, D. L., and Reid, M. B. (2000). Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidativestress and contractile dysfunction in mouse diaphragm. Circulation 102, 1690-1696.
93. Li, Z., Colucci-Guyon, E., Pinçon-Raymond, M., Mericskay, M., Pournin, S., Paulin, D., and Babinet, C. (1996). Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev. Biol. 175, 362-366.
94. Li, Z. P., Burke, E. P., Frank, J. S., Bennett, V., and Philipson, K. D (1993). The cardiac Na+-Ca2+ exchanger binds to the cytoskeletal protein ankyrin. J. Biol. Chem. 268, 11489-11491.
95. Lin, X., Gemel, J., Glass, A., Zemlin, C. W., Beyer, E. C., and Veenstra, R. D. (2010). Connexin40 and con-nexin43 determine gating properties of atrial gap junction channels. J. Mol. Cell. Cardiol. 48, 238-245.
96. Lindpaintner, K., Jin, M., Wilhelm, M. J., Suzuki, F., Linz, W., Schoelkens, B. A., and Ganten, D. (1988). Intracar-diac generation of angiotensin and its physiologic role. Circulation 77(6 Pt 2), I18-I23.
97. Liu, C., Liu, W., Palie, J., Lu, M. F., Brown, N. A., and Martin, J. F. (2002). Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions. Development 129, 5081-5091.
98. Lu, M. F., Pressman, C., Dyer, R., Johnson, R. L., and Martin, J. F. (1999). Function of Rieger syndrome gene in left-right asymmetry and cran-iofacial development. Nature 401, 276-278.
99. Lu, Y., Zhang, Y., Wang, N., Pan, Z., Gao, X., Zhang, F., Zhang, Y., Shan, H., Luo, X., Bai, Y., Sun, L., Song, W., Xu, C., Wang, Z., and Yang, B. (2010). MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122, 2378-2387.
100. Maier, S. K., Westenbroek, R. E., Schenkman, K. A., Feigl, E. O., Scheuer, T., and Catterall, W. A. (2002). An unexpected role for brain-type sodium channels in cou-plingof cell surface depolarization to contraction in the heart. Proc. Natl. Acad. Sci. U.S.A. 99, 4073-4078.
101. Mancarella, S., Yue, Y., Karnabi, E., Qu, Y., El-Sherif, N., and Boutjdir, M. (2008). Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1D L-type Ca2+ channel KO mouse. Am. J. Physiol. Heart Circ. Physiol. 295, H2017-H2024.
102. Marx, S. O., Kurokawa, J., Reiken, S., Motoike, H., D'Armiento, J., Marks, A. R., and Kass, R. S. (2002). Requirement of a macromolecularsignaling complex for beta adren-ergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295, 496-499.
103. Matherne, G. P., Linden, J., Byford, A. M., Gauthier, N. S., and Headrick, J. P. (1997). Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc. Natl. Acad. Sci. U.S.A. 94, 6541-6546.
104. Mathur,N.,Sood,S.,Wang,S.,van Oort, R. J., Sarma, S., Li, N., Skapura, D. G., Bayle, J. H., Valderrábano, M., and Wehrens, X. H. (2009). Sudden infant death syndrome in mice with an inherited mutation in RyR2. Circ. Arrhythm. Electrophysiol. 2, 677-685.
105. McPherron, A. C., Lawler, A. M., and Lee, S. J. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90.
106. Mende, U., Kagen, A., Cohen, A., Aramburu, J., Schoen, F. J., and Neer, E. J. (1998). Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc. Natl. Acad. Sci. U.S.A. 95, 13893-13898.
107. Meno, C., Shimono, A., Saijoh, Y., Yashiro, K., Mochida, K., Ohishi, S., Noji, S., Kondoh, H., and Hamada, H. (1998). lefty-1 is required for left-right determination as a regulator of lefty-2 and nodal. Cell 94, 287-297.
108. Milner, D. J., Weitzer, G., Tran, D., Bradley, A., and Capetanaki, Y. (1996). Disruption of muscle archi-tectureand myocardial degeneration in mice lacking desmin. J. Cell Biol. 134, 1255-1270.
109. Minamisawa, S., Wang, Y., Chen, J., Ishikawa, Y., Chien, K. R., and Mat-suoka, R. (2003). Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J. Biol. Chem. 278, 9570-9575.
110. Mohler, P. J., Davis, J. Q., and Bennett, V. (2005). Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol. 3, e423. doi:10.1371/journal.pbio.0030423
111. Mohler, P. J., Schott, J. J., Gramolini, A. O., Dilly, K. W., Guatimosim, S., duBell,W. H., Song,L. S., Haurogné, K., Kyndt, F., Ali, M. E., Rogers, T. B., Lederer, W. J., Escande, D., Le Marec, H., and Bennett, V. (2003). Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421, 634-639.
112. Mommersteeg, M. T., Brown, N. A., Prall, O. W., de Gier-de Vries, C., Harvey, R. P., Moorman, A. F., and Christoffels, V. M. (2007). Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ. Res. 101, 902-909.
113. Müller, F. U., Lewin, G., Baba, H. A., Bokník, P., Fabritz, L., Kirch-hefer, U., Kirchhof, P., Loser, K., Matus, M., Neumann, J., Rie-mann, B., and Schmitz, W. (2005). Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J. Biol. Chem. 280, 6906-6914.
114. Nakajima, Y., Yamagishi, T., Hokari, S., and Nakamura, H. (2000). Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat. Rec. 258, 119-127.
115. Namkung,Y., Skrypnyk, N.,Jeong,M.J., Lee, T., Lee, M. S., Kim, H. L., Chin, H., Suh, P. G., Kim, S. S., and Shin, H. S. (2001). Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation. J. Clin. Invest. 108, 1015-1022.
116. Neer, E. J. (1994). G proteins: critical control points for transmembrane signals. Protein Sci. 3, 3-14.
117. Nuyens, D., Stengl, M., Dugarmaa, S., Rossenbacker, T., Compernolle, V., Rudy, Y., Smits, J. F., Flameng, W., Clancy, C. E., Moons, L., Vos, M. A., Dewerchin, M., Benndorf, K., Collen, D., Carmeliet, E., and Carmeliet, P. (2001). Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat. Med. 7, 1021-1027.
118. Odermatt, A., Becker, S., Khanna, V. K., Kurzydlowski, K., Leisner, E., Pette, D., and MacLennan, D. H. (1998). Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle sarcoplasmic retic-ulum Ca2+-ATPase. J. Biol. Chem. 273, 12360-12369.
119. Ogata, T., Ueyama, T., Isodono, K., Tagawa, M., Takehara, N., Kawashima, T., Harada, K., Taka-hashi, T., Shioi, T., Matsubara, H., and Oh, H. (2008). MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance. Mol. Cell. Biol. 28, 3424-3436.
120. Olesen, M. S., Jespersen, T., Nielsen, J. B., Liang, B., Møller, D. V., Hedley,P., Christiansen, M., Varró, A., Ole-sen, S. P., Haunsø, S., Schmitt, N., and Svendsen, J. H. (2011). Mutations in sodium channel beta sub-unit SCN3B are associated with early onset lone atrial fibrillation. Cardio-vasc. Res. 89, 786-793.
121. Papadatos, G. A., Wallerstein, P. M., Head, C. E., Ratcliff, R., Brady, P. A., Benndorf, K., Saumarez, R. C., Trezise, A. E., Huang, C. L., Vanden-berg,J.I.,Colledge,W. H., and Grace, A.A. (2002). Slowed conduction and ventriculartachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc. Natl. Acad. Sci. U.S.A. 99, 6210-6215.
122. Park, P. S., Filipek, S., Wells, J. W., and Palczewski, K. (2004). Oligomeriza-tion of G protein-coupled receptors: past, present, and future. Biochemistry 43, 15643-15656.
123. Pfreimer, M., Vatter, P., Langer, T., Wieland, T., Gierschik, P., and Moepps, B. (2012). LARG links histamine-H1-receptor-activated Gq to Rho-GTPase-dependent signaling pathways. Cell. Signal. 24, 652-663.
124. Platzer, J., Engel, J., Schrott-Fischer, A., Stephan, K., Bova, S., Chen, H., Zheng, H., and Striessnig, J. (2000). Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell 102, 89-97.
125. Pretorius, L., Du, X. J., Woodcock, E. A., Kiriazis, H., Lin, R. C., Marasco, S., Medcalf, R. L., Ming, Z., Head, G. A., Tan, J. W., Cemerlang, N., Sadoshima, J., Shioi, T., Izumo, S., Lukoshkova, E. V., Dart, A. M., Jennings, G. L., and McMullen, J. R. (2009). Reduced phosphoinosi-tide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am. J. Pathol. 175, 998-1009.
126. Priori, S. G., Napolitano, C., and Schwartz, P. J. (1993). Cardiac receptor activation and arrhythmogene-sis. Eur. Heart J. 14(Suppl. E), 20-26.
127. Reil, J. C., Hohl, M., Oberhofer, M., Kazakov, A., Kaestner, L., Mueller, P., Adam, O., Maack, C., Lipp, P., Mewis, C., Allessie, M., Laufs, U., Böhm, M., and Neuberger, H. R. (2010). Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling. Cardiovasc. Res. 87, 485-493.
128. Remme, C. A., Verkerk, A. O., Nuyens, D., van Ginneken, A. C., van Brun-schot, S., Belterman, C. N., Wilders, R., van Roon, M. A., Tan, H. L., Wilde,A. A., Carmeliet, P.,de Bakker, J. M.,Veldkamp,M.W., and Bezzina,C. R. (2006). Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 114, 2584-2594.
129. Ridley, A. J., and Hall, A. (1992). Distinct patterns of actin organization regulated by the small GTP-binding proteins Rac and Rho. Cold Spring Harb. Symp. Quant. Biol. 57, 661-671.
130. Rosenberg, M. A., Das, S., Quintero Pinzon, P., Knight, A., Sosnovik, D., Ellinor, P. T., and Rosenzweig, A. (2012). A novel transgenic mouse model of cardiac hypertrophy and atrial fibrillation. J. Atr. Fibrillation 2.
131. Ruan, Y., Denegri, M., Liu, N., Bachetti, T., Seregni, M., Morotti, S., Sev-eri, S., Napolitano, C., and Priori, S. G. (2010). Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. Circ. Res. 106, 1374-1383.
132. Russell, J. C., and Proctor, S. D. (2006). Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc. Pathol. 15, 318-330.
133. Ryan, A. K., Blumberg, B., Rodriguez-Esteban, C., Yonei-Tamura, S., Tamura, K., Tsukui, T., de la Peña, J., Sabbagh, W., Greenwald, J., Choe, S., Norris, D. P., Robertson, E. J., Evans, R. M., Rosenfeld, M. G., and Izpisúa Belmonte, J. C. (1998). Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature 394, 545-551.
134. Saba, S., Janczewski, A. M., Baker, L. C., Shusterman, V., Gursoy, E. C., Feldman,A. M., Salama, G., McTier-nan, C. F., and London, B. (2005). Atrial contractile dysfunction, fibro-sis, and arrhythmias in a mouse modelof cardiomyopathysecondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. Am. J. Physiol. Heart Circ. Physiol. 289, H1456-H1467.
135. Sah, V. P., Hoshijima, M., Chien, K. R., and Brown, J. H. (1996). Rho is required for Galphaq and alpha1-adrenergic receptor signaling in car-diomyocytes. Dissociation of Ras and Rho pathways. J. Biol. Chem. 271, 31185-31190.
136. Sah, V. P., Minamisawa, S., Tam, S. P., Wú, T.H. Dorn G.W., Ross, Jr. J., Chien, K. R., and Brown, J. H. (1999). Cardiac-specific overexpres-sion of RhoA results in sinus and atrioventricular nodal dysfunctionand contractile failure. J. Clin. Invest. 103, 1627-1634.
137. Salazar, N. C., Chen, J., and Rock-man, H. A. (2007). Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim. Biophys. Acta 1768, 1006-1018.
138. Sampson, K. J., Terrenoire, C., Cervantes, D. O., Kaba, R. A., Peters, N. S., and Kass, R. S. (2008). Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an I Ks transgenic mouse. J. Physiol. (Lond.) 586, 627-637.
139. Sancho, J., Re, R., Burton, J., Barger, A. C., and Haber, E. (1976). The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation 53, 400-405.
140. Sawaya, S. E., Rajawat, Y. S., Rami, T. G., Szalai, G., Price, R. L., Siva-subramanian, N., Mann, D. L., and Khoury, D. S. (2007). Downregula-tion of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am. J. Physiol. Heart Circ. Physiol. 292, H1561-H1567.
141. Schott, J. J., Charpentier, F., Peltier, S., Foley, P., Drouin, E., Bouhour, J. B., Donnelly, P., Vergnaud, G., Bachner, L., Moisan, J. P., Le Marec, H., and Pascal, O. (1995). Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am. J. Hum. Genet. 57, 1114-1122.
142. Schotten, U., Verheule, S., Kirchhof, P., and Goette, A. (2011). Pathophys-iological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 91, 265-325.
143. Schrickel, J. W., Brixius, K., Herr, C., Clemen, C. S., Sasse, P., Reetz, K., Grohé, C., Meyer, R., Tiemann, K., Schröder, R., Bloch, W., Nickenig, G., Fleischmann, B. K., Noegel, A. A., Schwinger, R. H., and Lewal-ter, T. (2007). Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardio-vasc. Res. 76, 257-268.
144. Schrickel, J. W., Stöckigt, F., Krzyzak, W., Paulin, D., Li, Z., Lübkemeier, I., Fleischmann, B., Sasse, P., Linhart, M., Lewalter, T., Nickenig, G., Lick-fett, L., Schröder, R., and Clemen, C. S. (2010). Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysi-ological properties in desmin deficient mice. J. Interv. Card. Electro-physiol. 28, 71-80.
145. Schweickert, A., Campione1, M., Stein-beisser, H., and Blum, M. (2000).Pitx2 isoforms: involvement of Pitx2c but not Pitx2a or Pitx2b in vertebrate left-right asymmetry. Mech. Dev. 90, 41-51.
146. Scotland, P., Zhou, D., Benveniste, H., and Bennett,V. (1998). Nervous system defectsof AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J. Cell Biol. 143, 1305-1315.
147. Shanmugam, M., Molina, C. E., Gao, S., Severac-Bastide, R., Fischmeister, R., and Babu, G. J. (2011). Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic retic-ulum Ca2+ uptake in human atrial fibrillation. Biochem. Biophys. Res. Commun. 410, 97-101.
148. Shaw, R. M., and Rudy, Y. (1997). Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ. Res. 81, 727-741.
149. Sivasubramanian, N., Coker,M. L., Kur-relmeyer, K. M., MacLellan, W. R., DeMayo, F. J., Spinale, F. G., and Mann, D. L. (2001). Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104, 826-831.
150. Sood, S., Chelu, M. G., van Oort, R. J., Skapura, D., Santonastasi, M., Dobrev, D., and Wehrens, X. H. (2008). Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm 5, 1047-1054.
151. Stewart, A. F., Suzow, J., Kubota, T., Ueyama, T., and Chen,H. H. (1998). Transcription factor RTEF-1 mediates alpha1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ. Res. 83, 43-49.
152. Sussman, M. A., Welch, S., Walker, A., Klevitsky, R., Hewett, T. E., Price, R. L., Schaefer, E., and Yager, K. (2000). Altered focal adhesion regulation correlates with cardiomy-opathy in mice expressing constitu-tively active rac1. J. Clin. Invest. 105, 875-886.
153. Sweeney, L. J., Nag, A. C., Eisenberg, B., Manasek, F. J., and Zak, R. (1985). Developmental aspects of cardiac contractile proteins. Basic Res. Car-diol. 80(Suppl. 2), 123-127.
154. Temple, J., Frias, P., Rottman, J., Yang, T., Wu, Y., Verheijck, E. E., Zhang, W.,Siprachanh,C., Kanki,H.,Atkin-son, J. B., King, P., Anderson, M. E., Kupershmidt, S., and Roden, D. M. (2005). Atrial fibrillation in KCNE1-null mice. Circ. Res. 97, 62-69.
155. Thibodeau, I. L., Xu, J., Li, Q., Liu, G., Lam, K., Veinot, J. P., Birnie, D H., Jones, D. L., Krahn, A. D., Lemery, R., Nicholson, B. J., and Gollob, M. H. (2010). Paradigm of genetic mosaicism and lone atrial fibrillation: physiological character ization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 122, 236-244.
156. Tsai, C. T., Tseng, C. D., Hwang, J. J., Wu, C. K., Yu, C. C., Wang, Y. C., Chen, W. P., Lai, L. P., Chiang, F. T., and Lin, J. L. (2011). Tachycardia of atrial myocytes induces collagen expression in atrial fibrob-lasts through transforming growth factor beta1. Cardiovasc. Res. 89, 805-815.
157. Tupling, A. R., Asahi, M., and MacLen-nan, D. H. (2002). Sarcolipin over-expression in rat slow twitch muscle inhibits sarcoplasmic reticulum Ca2+ uptake and impairs contractile function. J. Biol. Chem. 277, 44740-44746.
158. Uemura, N., Ohkusa, T., Hamano, K., Nakagome, M., Hori, H., Shimizu, M., Matsuzaki, M., Mochizuki, S., Minamisawa, S., and Ishikawa, Y. (2004). Down-regulation of sarcol-ipin mRNA expression in chronic atrial fibrillation. Eur. J. Clin. Invest. 34, 723-730.
159. Ueyama, T., Zhu, C., Valenzuela, Y. M., Suzow, J. G., and Stewart, A. F. (2000). Identification of the functional domain in the transcription factor RTEF-1 that mediates alpha 1-adrenergic signaling in hypertro-phied cardiac myocytes. J. Biol. Chem. 275, 17476-17480.
160. Vaidya, D., Morley, G. E., Samie, F. H., and Jalife, J. (1999). Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis. Circ. Res. 85, 174-181.
161. van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., and Olson, E N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579.
162. Verheule, S. (1999). Cardiac conduction abnormalities in mice lacking the gap junction protein con-nexin40. J. Cardiovasc. Electrophys-iol. 10, 1380-1389.
163. Verheule, S., Sato, T., Everett, T. IV, Engle, S. K., Otten, D., Rubart-von der Lohe,M.,Nakajima,H.O.,Naka-jima, H., Field, L. J., and Olgin, J. E. (2004). Increased vulnerability to atrial fibrillation in transgenicmice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ. Res. 94, 1458-1465.
164. Wakili, R., Voigt, N., Kääb, S., Dobrev, D., and Nattel, S. (2011). Recent advances in the molecular patho-physiology of atrial fibrillation. J. Clin. Invest. 121, 2955-2968.
165. Wang, D. W., Yazawa, K., George, A. L. Jr., and Bennett, P. B. (1996). Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc. Natl. Acad. Sci. U.S.A. 93, 13200-13205.
166. Wang, J., Klysik, E., Sood, S., Johnson, R. L., Wehrens, X. H., and Martin, J. F. (2010). Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification.Proc. Natl. Acad. Sci. U.S.A. 107, 9753-9758.
167. Wang, Z., Lu, Y., and Yang, B. (2011). MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc. Res. 89, 710-721.
168. Watanabe, H., Yang, T., Stroud, D. M., Lowe, J. S., Harris, L., Atack, T. C., Wang, D. W., Hipkens, S. B., Leake, B., Hall, L., Kupershmidt, S., Chopra, N., Magnuson, M. A., Tanabe, N., Knollmann, B. C., George, A. L. Jr., and Roden, D. M. (2011). Striking in vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation 124, 1001-1011.
169. Wehrens, X. H., Lehnart, S. E., Huang, F., Vest, J. A., Reiken, S. R., Mohler, P. J., Sun, J., Guatimosim, S., Song, L. S., Rosemblit, N., D'Armiento, J. M., Napolitano, C., Memmi, M., Priori, S. G., Lederer, W. J., and Marks, A. R. (2003). FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113, 829-840.
170. Wei, L., Taffet, G. E., Khoury, D. S., Bo, J., Li,Y.,Yatani,A., Delaughter,M. C., Klevitsky, R., Hewett, T. E., Robbins, J., Michael, L. H., Schneider, M. D., Entman, M. L., and Schwartz, R. J. (2004). Disruption of Rho signaling results in progressive atrioventric-ular conduction defects while ventricular function remains preserved. FASEB J. 18, 857-859.
171. Wilde, A. A., and Brugada, R. (2011). Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ. Res. 108, 884-897.
172. Wu, J., Zhang, Y., Zhang, X., Cheng, L., Lammers, W. J., Grace, A. A., Fraser, J. A., Zhang, H., Huang, C. L., and Lei,M. (2012). Altered sinoatrial node function and intra-atrial conduction in murine gain-of-function Scn5a+/deltaKPQ hearts suggest an overlap syndrome. Am. J. Physiol. Heart Circ. Physiol. 302, H1510- H1523.
173. Xiao, H. D., Fuchs, S., Campbell, D. J., Lewis, W., Dudley, S. C. Jr., Kasi, V. S., Hoit, B. D., Keshelava, G., Zhao, H., Capecchi, M. R., and Bernstein, K. E. (2004). Mice with cardiac-restricted angiotensin-converting enzyme(ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.Am. J. Pathol.165, 1019-1032.
174. Xie, L. H., Shanmugam, M., Park, J. Y., Zhao, Z., Wen, H., Tian, B., Peri-asamy, M., and Babu, G. J. (2012). Ablationof sarcolipin resultsin atrial remodeling.Am. J. Physiol. CellPhys-iol. 302, 1762-1771.
175. Xu, S., Liu, A. C., and Gotlieb, A. I. (2010). Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta. Cardiovasc. Pathol. 19, 236-247.
176. Yeh, Y. H., Kuo, C. T., Chan, T. H., Chang, G. J., Qi, X. Y., Tsai, F., Nattel, S., and Chen, W. J. (2011). Transforming growth factor-beta and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes. Cardiovasc. Res. 91, 62-70.
177. Yue, L., Feng, J., Gaspo, R., Li, G. R., Wang, Z., and Nattel, S. (1997). Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res. 81, 512-525.
178. Zellerhoff, S., Pistulli, R., Mönnig, G., Hinterseer, M., Beckmann, B. M., Köbe, J., Steinbeck, G., Kääb, S., Haverkamp,W.,Fabritz, L.,Gradaus, R., Breithardt, G., Schulze-Bahr, E., Böcker, D., and Kirchhof, P. (2009). Atrial arrhythmias in long QT syndrome - a nested case control study. J. Cardiovasc. Electrophysiol. 20, 401-407.
179. Zhang, X., Chen, S.,Yoo, S., Chakrabarti, S., Zhang, T., Ke, T., Oberti, C., Yong, S. L., Fang, F., Li, L., de la Fuente, R.,Wang,L., Chen, Q., and Wang,Q. K. (2008). Mutation in nuclear pore component NUP155 leads to atrialfibrillation and early sudden cardiac death. Cell 135, 1017-1027.
180. Zhang, Y., Fraser, J. A., Jeevaratnam, K., Hao, X., Hothi, S. S., Grace, A. A., Lei, M., and Huang, C. L. (2011). Acute atrial arrhyth-mogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts. Cardiovasc. Res. 89, 794-804.
181. Zhang, Z., He, Y., Tuteja, D., Xu, D., Timofeyev, V., Zhang, Q., Glatter, K. A., Xu, Y., Shin, H. S., Low, R., and Chiamvimonvat, N. (2005). Functional roles of Cav1.3(alpha1D) calcium channels in atria: insights gained from gene-targeted null mutant mice. Circulation 112, 1936-1944.
182. Zhang, Z., Xu, Y., Song, H., Rodriguez, J., Tuteja, D., Namkung, Y., Shin, H. S., and Chiamvimonvat, N. (2002a). Functional roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ. Res. 90, 981-987.
183. Zhang, X., Yang, H., Yu, J., Chen, C., Zhang, G., Bao, J., Du, Y., Kibukawa, M., Li, Z., Wang, J., Hu, S., Dong, W.,Wang,J., Gregersen, N., Niebuhr, E.,and Bolund,L. (2002b). Genomic organization, transcript variants and comparative analysis of the human nucleoporin 155 (NUP155) gene. Gene 288, 9-18.